Chemical and electrochemical oxidation of 7-hydroxychlorpromazine
- 1 April 1978
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 21 (4) , 362-368
- https://doi.org/10.1021/jm00202a010
Abstract
The oxidation of 7-hydroxychlorpromazine, a process associated with several side-effects of chlorpromazine therapy, was examined in vitro by electrochemistry and rapid-scanning spectrophotometry. At pH 2, the oxidation results in a quantitative yield of 7,8-dioxochlorpromazine, but several intermediates are observable during the course of the reaction. These include a quinone imine with a half-life of 0.1 s, a monosubstituted benzoquinone with a half-life of .apprx. 50 s, and a disubstituted benzoquinone with a half-life of .apprx. 5 min. The concentrations of each intermediate were determined quantitatively as a function of time, and a complete oxidation mechanism is proposed. At pH 7, the yield of 7,8-dioxochlorpromazine is less than at pH 2, and an additional reaction pathway involving direct hydroxylation of the quinone imine is observed. The relationship of these reactions to the pharmacology of the hydroxylated chlorpromazine metabolites in animals and in humans is discussed.This publication has 1 reference indexed in Scilit:
- Metabolism of Chlorpromazine. IV. Identification of 7-Hydroxychlor-promazine and Its Sulfoxide and Desmethyl Derivatives.Experimental Biology and Medicine, 1963